Bayer Schering Forges Women's Health Research Partnership With Beijing's People's Liberation Army General Hospital
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Bayer Schering Pharma AG has forged a long-term strategic research partnership in the area of women's health with the People's Liberation Army General Hospital, known as 301 Hospital, in Beijing
You may also be interested in...
Could "Calculated Risks" In China Help Solve Global R&D Challenges? Bayer Thinks So
SHANGHAI - China could serve as the catalyst for a new model of dealmaking that emphasizes more flexible and strategic partnerships to drive R&D productivity, but only if Big Pharma is willing to take "calculated risks," according to Bayer Healthcare AG Chairman Jorg Reinhardt
Could "Calculated Risks" In China Help Solve Global R&D Challenges? Bayer Thinks So
SHANGHAI - China could serve as the catalyst for a new model of dealmaking that emphasizes more flexible and strategic partnerships to drive R&D productivity, but only if Big Pharma is willing to take "calculated risks," according to Bayer Healthcare AG Chairman Jorg Reinhardt
China Hastens New Drug Development, Bayer Starts 20 New Clinical Trials
Bayer HealthCare China President Li Xilie, revealed April 28 that Bayer Schering Pharma started 20 new drug clinical trials in China last year